InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Alloway Paul. Officer active across 2 companies, notably Homology Medicines, Inc.. In total, 7 disclosures have been recorded. Split: 0 buy · 4 sells. Total volume traded: €29k. Activity tracked since 9 January 2023. The latest transaction was disclosed on 25 March 2024 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Alloway Paul is a declarant linked to Homology Medicines, Inc. and Q32 Bio Inc. in the 7 filings recorded. The 7 sampled filings, covering the period from 2023-01-04 to 2024-04-23, show sales of EUR 28669 and no purchases.